Canada
US
Erik T. Engelson,
President & CEO of Lucira Health
Lorem ipsum dolor sit amet consectetur adipiscing elit dolor
On April 21, 2022 Lucira Health and USA Boxing announce exclusive partnership for the 2022 season.
The next generation of test-to-treat diagnostics is here, and we’re on a mission to make healthcare accessible to all.
On March 30, 2022 Lucira Health announces that its PCR-Quality At-Home COVID-19 Test Now Available Direct to Consumers in Canada.
These self-tests have been authorized by Health Canada under an Interim Order Authorization. The Lucira COVID-19 & Flu Test has been authorized only for the testing of nasal swabs from symptomatic individuals for the detection of nucleic acid from SARS-CoV-2, influenza A, and influenza B, not for any other viruses or pathogens. The Lucira COVID-19 Test has been authorized for testing of nasal swabs from individuals with or without symptoms for the detection of nucleic acid from SARS-CoV-2, not for any other viruses or pathogens.
To request more information contact us or call customer support at 1-888-582-4724
Monday -Friday 7:00am-5:00pm PT
For general media inquiries, please contact Lucira@luckybreakpr.com. If your media request is urgent, please contact: media@lucirahealth.com
© 2023 Lucira Health, Inc. All rights reserved.
